TLX — Telix Pharmaceuticals Ltd

—
Nasdaq · Health Care · Pharmaceuticals · CIK 2007191 ·
Last close
$8.85
Market Cap
$3.01B
52W High
$13.11
52W Low
$6.28
ADV30
336,690
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — 1,361,851,000 251,910,000 874,176,000
Dec 2025 — — — — 1,163,986,000 141,866,000 748,610,000
Jun 2025 — — — — 1,189,952,000 207,156,000 768,011,000

Balance + Analyst (yfinance extras)

Retained Earnings
$-110,896,000
Inventory
$39,029,000
Receivables
$170,388,000
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$890,785,024
EBITDA
$69,806,000
Free Cash Flow
$-62,596,000
Enterprise Value
$4,164,115,712
Total Cash
$251,910,000
Total Debt
$579,860,992
Shares Out
339,784,294
Trailing EPS
$0.10
Book Value
$1.44
ROE
7.4%
ROA
2.7%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 803,794,000 18,053,000 -7,125,000 1,163,986,000 748,610,000 415,376,000 —
Dec 2024 516,551,000 55,584,000 33,685,000 940,379,000 587,442,000 352,937,000 —
Dec 2023 332,978,000 34,965,000 4,208,000 277,258,000 174,613,000 102,645,000 —
Dec 2022 108,913,289 -50,475,530 -70,804,931 173,716,614 119,287,862 54,428,752 —

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.15

Peers — same industry

TickerNameMarket CapLastDaily %
DYN Dyne Therapeutics, Inc. $3.00B $16.02 —
XERS Xeris Biopharma Holdings, Inc. $3.07B $16.80 —
BGM BGM Group Ltd. $3.09B $8.13 —
ZLAB Zai Lab Ltd $2.91B $23.53 —
LEGN Legend Biotech Corp $3.13B $16.11 —

News headlines (Yahoo Finance, 1h cache)

Telix to Participate in UBS Global Biopharma Conference
2026-11-11 07:00 · Yahoo
Telix Joins Thera4Care with TLX400-Tx to Accelerate Translation of Next Generation FAP-Targeting Theranostics
2026-11-05 05:30 · Yahoo
Telix Pharmaceuticals Targets $1.5B Revenue as ITM Deal Speeds Therapy Push
2026-11-04 08:14 · Yahoo
Telix Reports Third Quarter 2026 Financial Performance
2026-10-20 22:10 · Yahoo
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
2026-10-19 05:30 · Yahoo
Profound Medical Corp (PROF) (Q3 2026) Earnings Call Highlights: Revenue Surges 86% as Pipeline ...
2026-11-06 05:26 · Yahoo
Talanx Q3 Earnings Call Highlights
2026-11-12 11:13 · Yahoo
3 Australian Growth Stocks With Revenue Growth Up To 52%
2026-11-07 13:11 · Yahoo
Regis Healthcare And 2 Other Australian Insider Owned Growth Stocks
2026-11-04 05:14 · Yahoo
3 Australian Growth Stocks With Revenue Growth Up To 17%
2026-11-03 04:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.